IBDEI0RC ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12824,1,3,0)
 ;;=3^Acute Lymphangitis of Chest Wall
 ;;^UTILITY(U,$J,358.3,12824,1,4,0)
 ;;=4^L03.323
 ;;^UTILITY(U,$J,358.3,12824,2)
 ;;=^5009057
 ;;^UTILITY(U,$J,358.3,12825,0)
 ;;=L03.324^^53^582^17
 ;;^UTILITY(U,$J,358.3,12825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12825,1,3,0)
 ;;=3^Acute Lymphangitis of Groin
 ;;^UTILITY(U,$J,358.3,12825,1,4,0)
 ;;=4^L03.324
 ;;^UTILITY(U,$J,358.3,12825,2)
 ;;=^5009058
 ;;^UTILITY(U,$J,358.3,12826,0)
 ;;=L03.325^^53^582^23
 ;;^UTILITY(U,$J,358.3,12826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12826,1,3,0)
 ;;=3^Acute Lymphangitis of Perineum
 ;;^UTILITY(U,$J,358.3,12826,1,4,0)
 ;;=4^L03.325
 ;;^UTILITY(U,$J,358.3,12826,2)
 ;;=^5009059
 ;;^UTILITY(U,$J,358.3,12827,0)
 ;;=L03.326^^53^582^29
 ;;^UTILITY(U,$J,358.3,12827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12827,1,3,0)
 ;;=3^Acute Lymphangitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,12827,1,4,0)
 ;;=4^L03.326
 ;;^UTILITY(U,$J,358.3,12827,2)
 ;;=^5009060
 ;;^UTILITY(U,$J,358.3,12828,0)
 ;;=L03.329^^53^582^28
 ;;^UTILITY(U,$J,358.3,12828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12828,1,3,0)
 ;;=3^Acute Lymphangitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,12828,1,4,0)
 ;;=4^L03.329
 ;;^UTILITY(U,$J,358.3,12828,2)
 ;;=^5009062
 ;;^UTILITY(U,$J,358.3,12829,0)
 ;;=L08.9^^53^582^167
 ;;^UTILITY(U,$J,358.3,12829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12829,1,3,0)
 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,12829,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,12829,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,12830,0)
 ;;=L11.0^^53^582^9
 ;;^UTILITY(U,$J,358.3,12830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12830,1,3,0)
 ;;=3^Acquired Keratosis Follicularis
 ;;^UTILITY(U,$J,358.3,12830,1,4,0)
 ;;=4^L11.0
 ;;^UTILITY(U,$J,358.3,12830,2)
 ;;=^5009091
 ;;^UTILITY(U,$J,358.3,12831,0)
 ;;=L20.0^^53^582^90
 ;;^UTILITY(U,$J,358.3,12831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12831,1,3,0)
 ;;=3^Besnier's Prurigo
 ;;^UTILITY(U,$J,358.3,12831,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,12831,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,12832,0)
 ;;=L20.81^^53^582^87
 ;;^UTILITY(U,$J,358.3,12832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12832,1,3,0)
 ;;=3^Atopic Neurodermatitis
 ;;^UTILITY(U,$J,358.3,12832,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,12832,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,12833,0)
 ;;=L20.82^^53^582^150
 ;;^UTILITY(U,$J,358.3,12833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12833,1,3,0)
 ;;=3^Flexural Eczema
 ;;^UTILITY(U,$J,358.3,12833,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,12833,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,12834,0)
 ;;=L20.84^^53^582^162
 ;;^UTILITY(U,$J,358.3,12834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12834,1,3,0)
 ;;=3^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,12834,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,12834,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,12835,0)
 ;;=L20.89^^53^582^85
 ;;^UTILITY(U,$J,358.3,12835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12835,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,12835,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,12835,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,12836,0)
 ;;=L20.9^^53^582^86
 ;;^UTILITY(U,$J,358.3,12836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12836,1,3,0)
 ;;=3^Atopic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12836,1,4,0)
 ;;=4^L20.9
 ;;^UTILITY(U,$J,358.3,12836,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,12837,0)
 ;;=L21.8^^53^582^262
 ;;^UTILITY(U,$J,358.3,12837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12837,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
